GO:0055056 D-glucose transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055056 defines the molecular function that enables transfer of D-glucose across a membrane.
• Glucose transporters are polytopic membrane proteins that mediate facilitated diffusion or active transport of D-glucose.
• D-glucose transmembrane transporter activity is essential for insulin secretion by pancreatic beta cells.
• These transporters also influence drug pharmacokinetics by mediating membrane transport of xenobiotics.
• Regulation involves trafficking and phosphorylation events, including AMPK-mediated control of alpha-arrestins.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of transporter function.
Description
D-glucose transmembrane transporter activity (GO:0055056) is a molecular function that enables the transfer of the D-enantiomer of the hexose monosaccharide glucose from one side of a membrane to the other. This activity is fundamental to cellular energy homeostasis, as glucose is a primary metabolic substrate for most mammalian cells. The transporters responsible for this function are integral membrane proteins that facilitate the movement of glucose across the lipid bilayer, either down its concentration gradient or against it, depending on the transporter family and cellular context. Researchers study this activity to understand metabolic regulation, hormone secretion, and the cellular uptake of glucose-derived drugs. The activity is also relevant to drug development because many therapeutic agents rely on glucose transporters for membrane permeation.
D-glucose transmembrane transporter activity At A Glance
| GO ID | GO:0055056 |
|---|---|
| GO term | D-glucose transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Transfer of D-glucose across a membrane |
| Substrate | D-glucose (D-enantiomer of glucose) |
| Cellular location | Plasma membrane and organelle membranes |
| Representative proteins | GLUT family (SLC2A), SGLT family (SLC5A), bacterial PtsG |
| Related diseases | Diabetes, cancer, metabolic disorders |
What Is GO:0055056?
According to the Gene Ontology, GO:0055056 describes the molecular function that enables the transfer of the D-enantiomer of the hexose monosaccharide glucose from one side of a membrane to the other. This activity is carried out by specific transmembrane proteins that bind D-glucose and mediate its translocation across biological membranes, without necessarily coupling to ATP hydrolysis or ion gradients, depending on the transporter class.
Why Is D-glucose transmembrane transporter activity Important in Cell Biology?
D-glucose transmembrane transporter activity is critical for maintaining glucose homeostasis in multicellular organisms. It governs the rate of glucose entry into cells, which directly affects insulin secretion by pancreatic beta cells, energy supply to neurons and muscle, and the pharmacokinetics of glucose-conjugated drugs. Dysregulation of this activity is linked to metabolic diseases, and the transporters themselves are targets for therapeutic intervention.
• Controls glucose uptake in insulin-sensitive tissues such as muscle and adipose tissue.
• Essential for glucose-stimulated insulin secretion in pancreatic beta cells.
• Mediates intestinal and renal glucose absorption via sodium-coupled transporters.
• Influences drug absorption and distribution through membrane transport of glucose-conjugated compounds.
• Regulated by cellular energy status through AMPK signaling and protein trafficking.
• Target for antidiabetic drugs, including SGLT2 inhibitors.
• Plays a role in cancer metabolism, where increased glucose uptake supports proliferation.
• Bacterial glucose transporters like PtsG are models for studying substrate specificity.
• Mutations in glucose transporter genes cause rare metabolic disorders such as GLUT1 deficiency syndrome.
• Facilitates the study of membrane protein topology and transport mechanisms.
What Happens During D-glucose transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs a glucose molecule from one side of the membrane.
D-glucose transmembrane transporters contain a central binding site that specifically recognizes the D-enantiomer of glucose. For facilitated diffusion transporters such as GLUT1, binding is stereospecific and saturable. In bacterial systems like PtsG, mutation of the binding pocket can alter substrate specificity to allow uptake of D-ribose, demonstrating the importance of precise molecular recognition.
Conformational change and translocation
In simple terms: The transporter changes shape to move glucose across the membrane.
After binding, the transporter undergoes a conformational change that exposes the glucose molecule to the opposite side of the membrane. This alternating access mechanism is a hallmark of solute carriers. The process does not require ATP for facilitated diffusion, but sodium-coupled transporters use the electrochemical gradient of Na+ to drive active transport.
Release of glucose
In simple terms: Glucose is released into the cell or extracellular space.
The transporter releases D-glucose on the trans side of the membrane, completing the transport cycle. Release is driven by the lower affinity of the binding site in the inward-facing conformation. The transporter then returns to its original conformation to begin a new cycle.
Regulation by trafficking and signaling
In simple terms: Cells control how many transporters are on the surface.
The activity of glucose transporters is regulated by their subcellular localization. Insulin promotes translocation of GLUT4 to the plasma membrane in muscle and fat cells. AMPK-mediated phosphorylation of alpha-arrestins regulates protein trafficking, including that of glucose transporters, in response to energy stress.
Key Genes Involved in GO:0055056 D-glucose transmembrane transporter activity
The following genes encode proteins that exhibit D-glucose transmembrane transporter activity or are directly involved in its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A1 (GLUT1) | Facilitated diffusion of glucose across the blood-brain barrier and in erythrocytes | Mutations cause GLUT1 deficiency syndrome; target for cancer metabolism studies |
| SLC2A2 (GLUT2) | Bidirectional glucose transport in liver, pancreas, and kidney | Important for glucose sensing in beta cells; linked to Fanconi-Bickel syndrome |
| SLC2A4 (GLUT4) | Insulin-regulated glucose uptake in muscle and adipose tissue | Key mediator of insulin resistance in type 2 diabetes |
| SLC5A1 (SGLT1) | Sodium-coupled glucose absorption in intestine and kidney | Target for SGLT inhibitors; studied for oral rehydration therapy |
| SLC5A2 (SGLT2) | Sodium-coupled glucose reabsorption in kidney proximal tubule | Target of SGLT2 inhibitors for diabetes treatment |
| PtsG | Bacterial phosphotransferase system glucose transporter | Model for studying substrate specificity and transport mechanism |
| G6PT (SLC37A4) | Glucose-6-phosphate transport across endoplasmic reticulum membrane | Mutations cause glycogen storage disease type Ib; topology studied |
| AKT2 | Serine/threonine kinase regulating GLUT4 translocation | Involved in insulin signaling and glucose uptake |
| PRKAA1/2 (AMPK) | Energy sensor regulating glucose transporter trafficking | Mediates alpha-arrestin phosphorylation and protein trafficking |
| ARRDC3 | Alpha-arrestin involved in AMPK-mediated trafficking | Regulates glucose transporter downregulation |
| INS | Insulin hormone that stimulates glucose uptake | Central to glucose homeostasis and diabetes research |
| GCK (Glucokinase) | Phosphorylates glucose after uptake | Glucose sensor in beta cells; mutations cause MODY2 |
| SLC2A3 (GLUT3) | High-affinity glucose transporter in neurons | Important for neuronal glucose uptake |
| SLC2A5 (GLUT5) | Fructose transporter with low glucose affinity | Studied for substrate discrimination |
| TBC1D4 (AS160) | Rab GTPase-activating protein regulating GLUT4 trafficking | Key node in insulin-stimulated glucose transport |
| RAB10 | Small GTPase involved in GLUT4 vesicle trafficking | Regulates glucose transporter recycling |
How Is D-glucose transmembrane transporter activity Regulated?
D-glucose transmembrane transporter activity is regulated at multiple levels. Acute regulation occurs through changes in transporter trafficking to and from the plasma membrane, as seen with insulin-stimulated GLUT4 translocation. AMPK-mediated phosphorylation of alpha-arrestins controls the ubiquitination and downregulation of glucose transporters in response to energy stress. Additionally, transcriptional regulation of SLC2A genes modulates total transporter abundance in response to metabolic demands.
D-glucose transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A1 | GLUT1 deficiency syndrome | Knockout or point mutation in neuronal cell lines; blood-brain barrier models |
| SLC2A4 | Type 2 diabetes / insulin resistance | Knockout in muscle cells; overexpression in adipocytes |
| SLC5A2 | Diabetes / renal glucose reabsorption | Knockout in kidney proximal tubule cells; knock-in of human variant |
| SLC37A4 | Glycogen storage disease type Ib | Point mutation knock-in in hepatocytes; knockout in liver cell lines |
| PtsG | Bacterial glucose uptake / substrate specificity | Point mutation in bacterial strains; overexpression for transport assays |
Diabetes mellitus and insulin resistance
Impaired glucose transporter activity contributes to insulin resistance in type 2 diabetes. Reduced GLUT4 translocation in muscle and adipose tissue leads to decreased glucose uptake, while SGLT2 inhibitors target renal glucose reabsorption to lower blood glucose. Insulin secretion defects in beta cells are also linked to altered glucose sensing via GLUT2 and glucokinase.
Cancer metabolism
Many cancers overexpress GLUT1 and other glucose transporters to support increased glycolytic flux, a phenomenon known as the Warburg effect. Targeting glucose transporters is being explored as an anticancer strategy. The role of glucose transporters in drug membrane transport also affects chemotherapy efficacy.
GLUT1 deficiency syndrome and rare metabolic disorders
Mutations in SLC2A1 cause GLUT1 deficiency syndrome, characterized by impaired glucose transport across the blood-brain barrier, leading to seizures and developmental delay. Similarly, mutations in SLC37A4 cause glycogen storage disease type Ib due to defective glucose-6-phosphate transport.
From D-glucose transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC2A1 affect glucose uptake? | CRISPR knockout in HEK293 or neuronal cells |
| Does a specific point mutation alter substrate specificity? | Point mutation knock-in in SLC2A1 or PtsG |
| Can a tagged transporter be used for localization studies? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of GLUT4 increase insulin sensitivity? | Overexpression in adipocytes or muscle cells |
| Which genes regulate glucose transporter trafficking? | CRISPR library screening for trafficking regulators |
| What is the effect of SGLT2 inhibitor on glucose transport? | Knockout of SLC5A2 in kidney cells followed by drug treatment |
How to Study the D-glucose transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled glucose uptake | Rate of D-glucose transport | Characterizing GLUT/SGLT activity in cells |
| Fluorescent glucose analog uptake | Real-time glucose influx | Live-cell imaging of transporter function |
| Patch-clamp electrophysiology | Electrogenic transport currents | Studying SGLT stoichiometry and kinetics |
| Cell surface biotinylation | Plasma membrane transporter abundance | Measuring GLUT4 translocation |
| Immunofluorescence microscopy | Subcellular localization of transporters | Visualizing trafficking in response to insulin |
| Co-immunoprecipitation | Protein-protein interactions | Identifying regulatory partners of transporters |
| CRISPR knockout screening | Genes required for glucose uptake | Identifying novel regulators of transporter activity |
| RNA-seq | Transcriptional changes in SLC2A genes | Assessing metabolic adaptation |
Transport assays using radiolabeled glucose
Uptake of 3H- or 14C-labeled D-glucose is measured in cells or membrane vesicles to quantify transporter activity. This method is standard for characterizing GLUT and SGLT family members.
Fluorescent glucose analogs and imaging
Fluorescent glucose analogs such as 2-NBDG allow real-time imaging of glucose uptake in live cells. This technique is useful for studying transporter localization and activity in response to stimuli.
Electrophysiology for electrogenic transporters
Sodium-coupled glucose transporters (SGLTs) generate currents during transport, which can be measured by patch-clamp or two-electrode voltage clamp in Xenopus oocytes expressing the transporter.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins associated with glucose transporters and post-translational modifications that regulate their activity.
How CRISPR Can Be Used to Study GO:0055056 D-glucose transmembrane transporter activity
Knockout
CRISPR knockout of SLC2A1, SLC2A4, or SLC5A2 in cell lines abolishes specific glucose transport activity, allowing researchers to attribute uptake to individual transporters. This approach is used to study compensatory mechanisms and drug specificity.
Point Mutation
Introducing point mutations in the glucose binding pocket of transporters (e.g., PtsG) can alter substrate specificity or transport kinetics. This helps map structure-function relationships.
Knock-in
Knock-in of fluorescent or affinity tags at endogenous SLC2A loci enables real-time tracking of transporter trafficking and localization without overexpression artifacts.
Overexpression
Overexpression of glucose transporters in cell lines or tissues increases glucose uptake capacity, useful for studying insulin sensitivity, cancer metabolism, or drug transport.
How EDITGENE Supports D-glucose transmembrane transporter activity Research
Researchers studying D-glucose transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in glucose transport, how mutations affect transporter function, and which regulatory pathways control transporter abundance. EDITGENE provides CRISPR-based cell models and screening services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for D-glucose transmembrane transporter activity research.
Frequently Asked Questions About D-glucose transmembrane transporter activity
What is D-glucose transmembrane transporter activity?
It is a molecular function (GO:0055056) that enables the transfer of D-glucose across a membrane, carried out by specific transporter proteins.
What genes are involved in D-glucose transmembrane transporter activity?
Key genes include SLC2A1 (GLUT1), SLC2A4 (GLUT4), SLC5A1 (SGLT1), SLC5A2 (SGLT2), and bacterial PtsG.
How is D-glucose transmembrane transporter activity regulated?
It is regulated by insulin-stimulated trafficking, AMPK-mediated phosphorylation of alpha-arrestins, and transcriptional control.
What diseases are associated with defects in glucose transporters?
GLUT1 deficiency syndrome, diabetes mellitus, and glycogen storage disease type Ib are linked to mutations in SLC2A1, SLC2A4, and SLC37A4, respectively.
What methods are used to study D-glucose transmembrane transporter activity?
Common methods include radiolabeled glucose uptake assays, fluorescent glucose analog imaging, electrophysiology, and proteomics.
Can CRISPR be used to study glucose transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect transporter function and regulation.
What is the role of GLUT4 in diabetes?
GLUT4 mediates insulin-stimulated glucose uptake in muscle and fat; its dysfunction contributes to insulin resistance in type 2 diabetes.
How do SGLT2 inhibitors work?
SGLT2 inhibitors block sodium-coupled glucose reabsorption in the kidney, lowering blood glucose independently of insulin.
What is the difference between GLUT and SGLT transporters?
GLUT transporters facilitate diffusion down a concentration gradient, while SGLT transporters use sodium gradient for active transport.
Why is D-glucose transmembrane transporter activity important for drug development?
Many drugs are conjugated to glucose to exploit transporter-mediated uptake, affecting drug absorption and targeting.
Conclusion
D-glucose transmembrane transporter activity (GO:0055056) is a fundamental molecular function that governs glucose entry into cells and is central to metabolism, hormone secretion, and drug transport. Understanding its mechanisms and regulation through CRISPR-based models can reveal new therapeutic targets for diabetes, cancer, and rare metabolic disorders. EDITGENE offers comprehensive services to accelerate this research.
References
- 2. Oka Y. 1996. [Glucose transporter].. Nihon Rinsho 54(3):632-7 PMID: 8904216
- 3. Täljedal IB. 1981. On insulin secretion.. Diabetologia 21(1):1-17 PMID: 7024025
- 4. Wang X et al.. 2020. Role of Glucose Transporters in Drug Membrane Transport.. Curr Drug Metab 21(12):947-958 PMID: 32778021
- 5. O'Donnell AF et al.. 2019. AMPK-Mediated Regulation of Alpha-Arrestins and Protein Trafficking.. Int J Mol Sci 20(3) PMID: 30691068
- 6. Wheeler TJ et al.. 1985. The glucose transporter of mammalian cells.. Annu Rev Physiol 47:503-17 PMID: 3888079
- 7. Pan CJ et al.. 1999. Transmembrane topology of human glucose 6-phosphate transporter.. J Biol Chem 274(20):13865-9 PMID: 10318794
- 8. Oh H et al.. 1999. A mutated PtsG, the glucose transporter, allows uptake of D-ribose.. J Biol Chem 274(20):14006-11 PMID: 10318813
